©The Author(s) 2021.
World J Psychiatr. Sep 19, 2021; 11(9): 543-552
Published online Sep 19, 2021. doi: 10.5498/wjp.v11.i9.543
Published online Sep 19, 2021. doi: 10.5498/wjp.v11.i9.543
Table 1 Large variations in outcome measures in longitudinal studies of opioid dependence[16]
| Domain | Reported among 27 studies included |
| Drug use | 21 of 27 |
| Crime | 13 of 27 |
| Health | 13 of 27 |
| Treatment-related outcomes | 16 of 27 |
| Social functioning | 13 of 27 |
| Harms | 8 of 27 |
| Mortality | 13 of 27 |
| Economic estimates | 2 of 27 |
- Citation: Soyka M, Franke AG. Recent advances in the treatment of opioid use disorders–focus on long-acting buprenorphine formulations. World J Psychiatr 2021; 11(9): 543-552
- URL: https://www.wjgnet.com/2220-3206/full/v11/i9/543.htm
- DOI: https://dx.doi.org/10.5498/wjp.v11.i9.543